Avoid common mistakes on your manuscript.
I have seen the future and it is very much like the present, only longer
(Kehlog Albran)
If we want to predict the future, we have to look at the past and the present. The COVID-19 pandemic has highlighted the need for intensive care unit (ICU) beds in an unprecendented manner. However, the reasons why we need more ICU beds are not new.
Changing demographics
Worldwide the population is growing and people live longer. This is mirrored in the increasing age of ICU patients. In many high income countries, the proportion of patients aged over 80 years has risen to 10–15% and is estimated to rise even further [1]. As the age of patients increases, we not only see more patients with increasing comorbidities and frailty but also increasing numbers of elderly patients with high functional status [2]. In addition, increasing numbers of children with corrected or supported congenital disorders are growing into adulthood. More ICU beds are required to treat all these growing populations.
New treatments equal more ‘ICU eligible’ patients
Historically, many ICU treatments were limited solely to patients most likely to benefit. However, as resources have increased, some have become ‘mainstay’ and available to more vulnerable and frail patients. During the influenza pandemic of 2009, extracorporeal membrane oxygenation was reserved for young otherwise healthy patients with respiratory failure. Today, indications have broadened and many more patients are eligible. Artificial organs and mechanical circulatory assist devices now offer long-term survival options to many patients in whom ICU care was previously not considered. Outside the ICU, the increasing availability of new anticancer therapies such as monoclonal antibodies, CAR-T cells and checkpoint inhibitors whose side effects may include severe organ failure is creating a growing cohort of patients who also need ICU admission. As a consequence, the increasing availability of all these treatments will result in greater demand for ICU care.
Only the sick will be in the hospital
Increasingly treatments are being delivered successfully to patients in the community, with only the sickest admitted to the hospital. As a consequence, in the near future, hospitalised patients will be more severely ill than those of today. A small increase in illness severity will then necessitate ICU admission [3]. This may already be a contributing factor in the increasing ICU admissions due to sepsis [4].
ICU for those previously considered ‘too well’ or ‘too sick’
Patients are increasingly admitted to ICU for observation, e.g. intoxicated patients waiting until the time of maximum toxin concentration has past [5]. Other patients need monitoring where therapy can be delivered urgently if required, such as those with potential airway compromise. Admission to an ICU results in better outcomes than admission to a hospital ward [6].
Can these patients be observed elsewhere? Yes, but only in areas adequately equipped and appropriately manned by well-trained staff. Failure to meet these high standards cannot be compensated for by medical emergency intervention teams who respond to deterioration after it has happened. It is time to accept that wards are not staffed and trained to adequately deal with such patients. More ICU beds will bring more patients to the personnel most likely to improve their outcomes.
In some hospitals, the ICU is the only facility which can provide optimal treatment to terminally ill patients requiring potent analgesic drugs or non-invasive ventilation. Increasingly, ICU admission is being offered to provide end-of-life care (e.g. to facilitate time for family members to attend patients with non-survivable brain injuries who were intubated prior to ICU admission, or to allow opportunities for organ donation, in turn saving the lives of others through transplantation) [7].
Developing countries and changing cultures
The largest increase in demand for ICU beds may come from middle income countries where more than half the global population live [8]. As schooling, social consciousness, wealth and healthcare systems improve, there will be increasing demand to care for the critically ill. This may be greatest in regions where cultural and religious attitudes about sanctity of life lead to indefinite continuation of treatments which might be withdrawn in other countries. Ultimately, those patients will be treated in long-term facilities, but, prior to that, they will stay in ICU longer [9].
Lack of ICU beds is a problem right now
When few ICU beds are available, delays in ICU admission hinder timely provision of care leading to worse outcomes [10, 11]. The impact of ICU strain on patient outcomes is already well-recognised today [12]. Lack of access to ICU puts patients at risk through increased interhospital transfers, cancellation of surgery and premature or out-of-hours discharge from the ICU [13]. Without more ICU beds, increasing pressure to admit patients will exacerbate ICU strain and leaves us little capacity to cope with sudden surges in ICU demand. ICUs in many countries have been overwhelmed by patients with coronavirus (SARS-CoV-2) infections. Lack of intensive care capacity has undoubtedly cost lives during the pandemic and will do again without greater baseline ICU capacity [14].
Looking at the present, it is clear we need more ICU beds to meet current demands, to improve care for our present patients and to cater for future patients. However, we can also deliver these ICU beds more efficiently and responsibly by streamlining processes of care which reduce ICU length of stay, using ICU telehealth, developing practitioner specialist roles and leveraging economies of scale in larger ICUs [15]. The need for ‘more ICU’ has never been more obvious than today as we watch a global pandemic overwhelm our present ICU resources. Let this be a lesson for the future (Table 1).
References
Flaatten H, de Lange DW, Artigas A, Bin D, Moreno R, Christensen S et al (2017) The status of intensive care medicine research and a future agenda for very old patients in the ICU. Intensive Care Med 43(9):1319–1328
Darvall JN, Bellomo R, Paul E, Subramaniam A, Santamaria JD, Bagshaw SM, Rai S, Hubbard RE, Pilcher D (2019) Frailty in very old critically ill patients in Australia and New Zealand: a population-based cohort study. Med J Aust. https://doi.org/10.5694/mja2.50329
Grieve R, O’Neill S, Basu A, Keele L, Rowan KM, Harris S (2019) Analysis of benefit of intensive care unit transfer for deteriorating ward patients: a patient-centered approach to clinical evaluation. JAMA Netw Open 2(2):e187704. https://doi.org/10.1001/jamanetworkopen.2018.7704
Duke GJ, Moran JL, Santamaria JD, Pilcher DV (2020) Sepsis in the new millennium—are we improving? J Crit Care 56:273–280. https://doi.org/10.1016/j.jcrc.2020.01.015
Hondebrink L, Rietjens SJ, Donker DW, Hunault CC, van den Hengel-Koot I, Verputten PM et al (2019) A quarter of admitted poisoned patients have a mild poisoning and require no treatment: an observational study. Eur J Intern Med 66:41–47. https://doi.org/10.1016/j.ejim.2019.05.012
Vranas KC, Jopling JK, Scott JY, Badawi O, Harhay MO, Slatore CG et al (2018) The association of ICU acuity with outcomes of patients at low risk of dying. Crit Care Med 46(3):347–353. https://doi.org/10.1097/CCM.0000000000002798
Melville A, Kolt G, Anderson D, Mitropoulos J, Pilcher D (2017) Admission to intensive care for palliative care or potential organ donation: demographics, circumstances, outcomes, and resource use. Crit Care Med 45(10):e1050–e1059. https://doi.org/10.1097/ccm.0000000000002655
Phua J, Faruq MO, Kulkarni AP, Redjeki IS, Detleuxay K, Mendsaikhan N, Sann KK, Shrestha BR, Hashmi M, Palo JEM, Haniffa R, Wang C, Hashemian SMR, Konkayev A, Mat Nor MB, Patjanasoontorn B, Nafees KMK, Ling L, Nishimura M, AlBahrani MJ, Arabi YM, Lim CM, Fang WF, Asian Analysis of Bed Capacity in Critical Care (ABC) Study Investigators, and the Asian Critical Care Clinical Trials Group (2020) Critical care bed capacity in Asian countries and regions. Crit Care Med 48(5):654–662. https://doi.org/10.1097/ccm.0000000000004222
Phua J, Joynt GM, Nishimura M, Deng Y, Myatra SN, Chan YH, Binh NG, Tan CC, Faruq MO, Arabi YM, Wahjuprajitno B, Liu SF, Hashemian SM, Kashif W, Staworn D, Palo JE, Koh Y, ACME Study Investigators; Asian Critical Care Clinical Trials Group (2016) Withholding and withdrawal of life-sustaining treatments in low-middle-income versus high-income Asian countries and regions. Intensive Care Med 42(7):1118–1127. https://doi.org/10.1007/s00134-016-4347-y
Stelfox HT, Hemmelgarn BR, Bagshaw SM, Gao S, Doig CJ, Nijssen-Jordan C, Manns B (2012) Intensive care unit bed availability and outcomes for hospitalized patients with sudden clinical deterioration. Arch Intern Med 172(6):467–474
Groenland CNL, Termorshuizen F, Rietdijk WJR, van den Brule J, Dongelmans DA, de Jonge E et al (2019) Emergency department to ICU time is associated with hospital mortality: a registry analysis of 14,788 patients from six university hospitals in The Netherlands. Crit Care Med 47(11):1564–1571. https://doi.org/10.1097/ccm.0000000000003957
Rewa OG, Stelfox HT, Ingolfsson A, Zygun DA, Featherstone R, Opgenorth D, Bagshaw SM (2018) Indicators of intensive care unit capacity strain: a systematic review. Crit Care 22(1):86. https://doi.org/10.1186/s13054-018-1975-3
Goldfrad C, Rowan K (2000) Consequences of discharges from intensive care at night. Lancet 355(9210):1138–1142
Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS (2020) Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. https://doi.org/10.1007/s00134-020-05979-7
Hicks P, Huckson S, Fenney E, Leggett I, Pilcher D, Litton E (2019) The financial cost of intensive care in Australia: a multicentre registry study. Med J Aust. https://doi.org/10.5694/mja2.50309
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr de Lange and Dr Pilcher has no conflicts to declare. Dr. Soares is founder and equity shareholder of Epimed Solutions®, which commercializes the Epimed Monitor System®, a cloud-based software for ICU management and benchmarking.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Lange, D.W., Soares, M. & Pilcher, D. ICU beds: less is more? No. Intensive Care Med 46, 1597–1599 (2020). https://doi.org/10.1007/s00134-020-06089-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-020-06089-0